This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sanofi-Aventis. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Prafulla Agrawala: Innovator in Pharmaceutical Formulations
Introduction
Prafulla Agrawala is a notable inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His work has led to advancements that benefit both the industry and patients.
Latest Patents
Prafulla Agrawala holds 1 patent for his invention titled "Fexofenadine suspension formulation." This patent is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I. This formulation is crucial for improving the delivery and effectiveness of the medication.
Career Highlights
Agrawala is associated with Sanofi-Aventis, a leading global biopharmaceutical company. His role at the company has allowed him to work on innovative solutions that enhance drug formulations and patient care.
Collaborations
Throughout his career, Prafulla has collaborated with esteemed colleagues, including Kazimierz Chrzan and Curtis J Porcello. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Prafulla Agrawala's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work continues to influence the development of effective medications that improve patient outcomes.